Literature DB >> 15801825

Enantiospecificity of glutamate carboxypeptidase II inhibition.

Takashi Tsukamoto1, Pavel Majer, Dilrukshi Vitharana, Chiyou Ni, Bunda Hin, Xi-Chun M Lu, Ajit G Thomas, Krystyna M Wozniak, David C Calvin, Ying Wu, Barbara S Slusher, David Scarpetti, George W Bonneville.   

Abstract

Two representative glutamate carboxypeptidase II (GCP II) inhibitors, 2-(hydroxypentafluorophenylmethyl-phosphinoylmethyl)pentanedioic acid 2 and 2-(3-mercaptopropyl)pentanedioic acid 3, were synthesized in high optical purities (>97%ee). The two enantiomers of 2 were prepared from previously reported chiral intermediates, (R)- and (S)-2-(hydroxyphosphinoylmethyl)pentanedioic acid benzyl esters 8. The synthesis of (R)- and (S)-3 involves the hydrolysis of (R)- and (S)-3-(2-oxo-tetrahydro-thiopyran-3-yl)propionic acids, (R)- and (S)-11, the corresponding optically pure thiolactones delivered by chiral chromatographic separation of the racemic 11. GCP II inhibitory assay revealed that (S)-2 is 40-fold more potent than (R)-2. In contrast, both enantiomers of 3 inhibited GCP II with nearly equal potency. The efficacy observed in subsequent animal studies with these enantiomers correlated well with the inhibitory potency in a GCP II assay.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15801825     DOI: 10.1021/jm049258g

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  7 in total

1.  Design and synthesis of a siderophore conjugate as a potent PSMA inhibitor and potential diagnostic agent for prostate cancer.

Authors:  Pingyu Ding; Paul Helquist; Marvin J Miller
Journal:  Bioorg Med Chem       Date:  2007-11-17       Impact factor: 3.641

2.  δ-Thiolactones as prodrugs of thiol-based glutamate carboxypeptidase II (GCPII) inhibitors.

Authors:  Dana V Ferraris; Pavel Majer; Chiyou Ni; C Ethan Slusher; Rana Rais; Ying Wu; Krystyna M Wozniak; Jesse Alt; Camilo Rojas; Barbara S Slusher; Takashi Tsukamoto
Journal:  J Med Chem       Date:  2013-12-27       Impact factor: 7.446

3.  Oral administration of the NAALADase inhibitor GPI-5693 attenuates cocaine-induced reinstatement of drug-seeking behavior in rats.

Authors:  Xiao-Qing Peng; Jie Li; Eliot L Gardner; Charles R Ashby; Ajit Thomas; Krystyna Wozniak; Barbara S Slusher; Zheng-Xiong Xi
Journal:  Eur J Pharmacol       Date:  2009-10-31       Impact factor: 4.432

4.  Structural basis of interactions between human glutamate carboxypeptidase II and its substrate analogs.

Authors:  Cyril Barinka; Klara Hlouchova; Miroslava Rovenska; Pavel Majer; Miroslawa Dauter; Niyada Hin; Yao-Sen Ko; Takashi Tsukamoto; Barbara S Slusher; Jan Konvalinka; Jacek Lubkowski
Journal:  J Mol Biol       Date:  2008-01-05       Impact factor: 5.469

5.  Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancer.

Authors:  Jeroen R Mesters; Cyril Barinka; Weixing Li; Takashi Tsukamoto; Pavel Majer; Barbara S Slusher; Jan Konvalinka; Rolf Hilgenfeld
Journal:  EMBO J       Date:  2006-02-09       Impact factor: 11.598

6.  Uncovering the Role of N-Acetyl-Aspartyl-Glutamate as a Glutamate Reservoir in Cancer.

Authors:  Tu Nguyen; Brian James Kirsch; Ryoichi Asaka; Karim Nabi; Addison Quinones; Jessica Tan; Marjorie Justine Antonio; Felipe Camelo; Ting Li; Stephanie Nguyen; Giang Hoang; Kiet Nguyen; Sunag Udupa; Christos Sazeides; Yao-An Shen; Amira Elgogary; Juvenal Reyes; Liang Zhao; Andre Kleensang; Kaisorn Lee Chaichana; Thomas Hartung; Michael J Betenbaugh; Suely K Marie; Jin G Jung; Tian-Li Wang; Edward Gabrielson; Anne Le
Journal:  Cell Rep       Date:  2019-04-09       Impact factor: 9.995

Review 7.  PSMA-targeting agents for radio- and fluorescence-guided prostate cancer surgery.

Authors:  Yvonne H W Derks; Dennis W P M Löwik; J P Michiel Sedelaar; Martin Gotthardt; Otto C Boerman; Mark Rijpkema; Susanne Lütje; Sandra Heskamp
Journal:  Theranostics       Date:  2019-09-20       Impact factor: 11.556

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.